{"result": "(\"entity\"<|>ASOCIACIÓN ESPAÑOLA DE FAMILIARES Y ENFERMOS DE WILSON<|>ORGANIZATION<|>The Asociación Española de Familiares y Enfermos de Wilson is a support group for families and patients affected by Wilson's disease, providing resources and information through their website.)\n##\n(\"entity\"<|>TRIENTINA<|>ORGANIZATION<|>Trientina, marketed as Syprine®, is a medication used to treat Wilson's disease by chelating copper and increasing its urinary excretion.)\n##\n(\"entity\"<|>COPPER<|>GEO<|>Copper is an essential trace element in the human diet, involved in various bodily functions, but excessive amounts can lead to health issues, particularly in Wilson's disease.)\n##\n(\"entity\"<|>WILSON'S DISEASE<|>EVENT<|>Wilson's disease is a hereditary autosomal recessive disorder that causes excessive copper accumulation in the body, leading to liver failure and neurological damage.)\n##\n(\"entity\"<|>PENICILAMINA<|>ORGANIZATION<|>Penicillamine is a medication used to treat Wilson's disease by chelating copper, but it is more potent than Trientina.)\n##\n(\"entity\"<|>ZINC ACETATE<|>ORGANIZATION<|>Zinc acetate is a treatment that blocks intestinal copper absorption and is used as a third-line agent in managing Wilson's disease.)\n##\n(\"relationship\"<|>TRIENTINA<|>WILSON'S DISEASE<|>Trientina is used as a treatment for Wilson's disease, helping to manage copper levels in patients<|>8)\n##\n(\"relationship\"<|>PENICILAMINA<|>WILSON'S DISEASE<|>Penicillamine is a primary treatment for Wilson's disease, effectively reducing copper accumulation<|>8)\n##\n(\"relationship\"<|>ZINC ACETATE<|>WILSON'S DISEASE<|>Zinc acetate is used as a secondary treatment for Wilson's disease, blocking copper absorption<|>7)\n##\n(\"relationship\"<|>ASOCIACIÓN ESPAÑOLA DE FAMILIARES Y ENFERMOS DE WILSON<|>WILSON'S DISEASE<|>The association provides support and resources for individuals and families affected by Wilson's disease<|>6)\n##\n(\"relationship\"<|>COPPER<|>WILSON'S DISEASE<|>Copper accumulation is the primary issue in Wilson's disease, leading to various health complications<|>9)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: tetraciclinas36.\nsentar un agravamiento de la sintomatología. Sus efec-\ntos adversos son comunes y son: hipersensibilidad,                   Tetratiomolidato de amonio\ngranulocitopenia, trombocitopenia, anemia aplásica,                    Es un tratamiento experimental no comercializado.\nsíndrome nefrótico, síndrome Goodpasture-like, lupus                 Produce complejos intestinales con el cobre y así redu-\ninducido por drogas, disgeusia, miastenia gravis, de-                ce su absorción. A dosis bajas extrae el cobre de las\npresión de IgA sérica, y polimiositis. Debe administrar-             metalotioneinas, pero a dosis altas forma complejos\nse conjuntamente con piridoxina (25 mg/día) para evi-                insolubles de cobre que se depositan en el hígado37.\ntar su déficit. Sus efectos adversos pueden ser un\nproblema para su uso crónico, por lo que habitual-\nmente se prefiere el zinc por su baja toxicidad35.                   8.11.    Grupos de apoyo\n                                                                       Asociación Española de Familiares y Enfermos de\nTrientina                                                            Wilson: http://enfermedaddewilson.org/.\n   Su nombre comercial es Syprine® (medicamento ex-\ntranjero nominal comercializado por laboratorios Merck               9.  Resumen y conclusiones\nen cápsulas de 250). Se enlaza o quela al cobre y conlle-              El cobre es un oligoelemento esencial en la dieta del\nva a un aumento de la excreción urinaria de cobre, aun-              hombre. Al igual que el hierro, participa en la síntesis\nque es menos potente y efectivo que la penicilamina,                 de la hemoglobina y es fundamental para el desarrollo\npor lo que es un quelante alternativo, se utiliza en pa-             y mantenimiento de huesos y tejido elástico como ten-\ncientes intolerantes a la penicilamina. La dosis es de               dones y tejido conectivo, así como del sistema vascular.\n900-2 700 mg al día repartido en varias dosis hasta la               La enfermedad de Wilson es una enfermedad heredita-\ndosis de mantenimiento que es de 900-1 500 mg/día.                   ria autosómico recesiva que hace que el cuerpo absor-\n   Como efectos secundarios destacan dermatitis de                   ba y retenga cantidades excesivas de cobre, lo cual\ncontacto, distonía, miastenia gravis, anemia ferropéni-              provoca insuficiencia hepática, daño del sistema ner-\nca o lupus eritematoso sistémico. Además, también                    vioso central y afectación sistémica en general. Se diag-\nquela el hierro y el zinc. Requiere suplementación oral              nostica por niveles de cobre elevados en orina y dismi-\nde hierro pero alejado de trientina, porque sus comple-              nuidos en sangre, con ceruloplasmina sérica baja y\njos de hierro son tóxicos. Debe administrarse 2 horas                afectación hepática con anemia hemolítica. El trata-\nantes o después de las comidas o de otro fármaco para                miento dietético se basa en la reducción de los alimen-\nevitar interacciones35.                                              tos ricos en cobre como vísceras, chocolate, frutos\n                                                                     secos y mariscos, aunque solo es coadyuvante al trata-\nAcetato de zinc                                                      miento farmacológico con D-penicilamina, trientina\n                                                                     y/o acetato de zinc.\n   Se pueden usar diferentes sales de zinc (sulfato, ace-\ntato o gluconato), con resultados similares. La dosis en             10.   Bibliografía\nadultos es de 50 mg de zinc elemental una hora antes\nde desayuno, comida y cena, y separado de los quelan-                1.  Hordyjewska A, Popiolek L, Kocot J. The many «fac-\ntes del cobre.                                                           es» of copper in medicine and treatment. Biomet-\n   Su mecanismo de acción es diferente a penicilamina                    als. 2014;27(4):611-21.\ny trientina. No es quelante, sino que bloquea la absor-              2.  Kivirikko KI, Peltonen L. Abnormalities in copper\nción del cobre intestinal, mediante la formación de me-                  metabolism and disturbances in the synthesis of\ntalotioneínas. Se recomienda no usarlo como trata-                       collagen and elastin. Med Biol.1982;60(2):45-8.\nmiento inicial sintomático, ya que su inicio de acción es            3. Schilsky ML, Oikonomou I. Inherited metabolic liver\nlento. Aunque se considera un agente de tercera línea,                  disease. Curr Opin Gastroenterol. 2005;21(3):275-82.\n---\n 434\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}